CLMB and neoplasm: In the current study, we investigated the mRNA expression levels of C16orf74 in human primary NMIBC tissues in a relatively large population with a long-term follow up period, along with several known clinical risk factors, including age, tumor size, number of tumors, T-category, tumor grade, and intravesical therapy [30]–[31].